Pharmacological treatment of obesity in patients with polycystic ovary syndrome

Hassan Kahal, Stephen Atkin, Thozhukat Sathyapalan

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of obesity has dramatically increased, with probable associated increase in PCOS. Weight reduction plays an integral part in the management of women with PCOS. In this paper, current available weight reduction therapies in the management of PCOS are discussed.

Original languageEnglish
Article number402052
JournalJournal of Obesity
Volume2011
DOIs
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Polycystic Ovary Syndrome
Obesity
Pharmacology
Weight Loss
Therapeutics

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Pharmacological treatment of obesity in patients with polycystic ovary syndrome. / Kahal, Hassan; Atkin, Stephen; Sathyapalan, Thozhukat.

In: Journal of Obesity, Vol. 2011, 402052, 2011.

Research output: Contribution to journalArticle

@article{4b5fd7f589324e289c2c3a62e1810b2b,
title = "Pharmacological treatment of obesity in patients with polycystic ovary syndrome",
abstract = "Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of obesity has dramatically increased, with probable associated increase in PCOS. Weight reduction plays an integral part in the management of women with PCOS. In this paper, current available weight reduction therapies in the management of PCOS are discussed.",
author = "Hassan Kahal and Stephen Atkin and Thozhukat Sathyapalan",
year = "2011",
doi = "10.1155/2011/402052",
language = "English",
volume = "2011",
journal = "Journal of Obesity",
issn = "2090-0708",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Pharmacological treatment of obesity in patients with polycystic ovary syndrome

AU - Kahal, Hassan

AU - Atkin, Stephen

AU - Sathyapalan, Thozhukat

PY - 2011

Y1 - 2011

N2 - Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of obesity has dramatically increased, with probable associated increase in PCOS. Weight reduction plays an integral part in the management of women with PCOS. In this paper, current available weight reduction therapies in the management of PCOS are discussed.

AB - Polycystic ovary syndrome (PCOS) is a common disorder affecting women of reproductive age and it is associated with increased cardiovascular risk. Obesity plays an important role in the pathogenesis of PCOS, and the majority of patients with PCOS are obese. Over the last 20 years, the prevalence of obesity has dramatically increased, with probable associated increase in PCOS. Weight reduction plays an integral part in the management of women with PCOS. In this paper, current available weight reduction therapies in the management of PCOS are discussed.

UR - http://www.scopus.com/inward/record.url?scp=84869880616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869880616&partnerID=8YFLogxK

U2 - 10.1155/2011/402052

DO - 10.1155/2011/402052

M3 - Article

AN - SCOPUS:84869880616

VL - 2011

JO - Journal of Obesity

JF - Journal of Obesity

SN - 2090-0708

M1 - 402052

ER -